You are viewing: UK Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The UK Biopreservation Market was valued at $118.3 Million in 2024 and projected to reach to $186.7 Million by 2029, representing a compound annual growth rate of 9.6%. The UK biopreservation market is poised for sustained expansion, growing from $118.3 million in 2024 to $186.7 million by 2029, representing a 9.6% CAGR.

UK Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Biopreservation Market Trends and Insights

  • The UK's advanced healthcare infrastructure and strong investment in regenerative medicine and cell therapy research are driving demand for sophisticated biopreservation solutions.
  • The UK's regulatory framework and leadership in life sciences innovation position it as a key hub for biopreservation technology adoption across Europe. In 2024, the UK biopreservation market benefits from increasing adoption in clinical applications, research institutions, and biobanking facilities.
  • The UK's commitment to precision medicine and growing prevalence of chronic diseases are accelerating the need for reliable sample preservation technologies.
  • By 2029, the UK market is expected to capture significant value as healthcare providers and research organizations expand their biopreservation capabilities to support emerging therapeutic modalities..

Key Market Statistics

  • CAGR (2024-2029) 9.6% CAGR
  • Market Size, 2024 ~USD 118.3 Million
  • Forecast, 2029 ~USD 186.7 Million
  • Country UK

UK Biopreservation Market Overview

Market Valuation :

The UK biopreservation market is valued at $118.3 million in 2024, with strong growth trajectory positioning it as a key segment within the European life sciences sector.

Regulatory Leadership :

The UK's robust regulatory framework and post-Brexit autonomy in life sciences governance are accelerating adoption of advanced biopreservation technologies across NHS trusts and private research institutions.

Regenerative Medicine Hub :

Investment in UK-based cell therapy and regenerative medicine research, particularly in London and Cambridge, is driving demand for cryopreservation and biobanking solutions.

Healthcare Infrastructure :

Advanced hospital networks and research facilities across the UK are increasingly integrating sophisticated biopreservation systems to support clinical trials and therapeutic development.

UK Biopreservation Market Dynamics

  • This growth is underpinned by the UK's position as a global leader in regenerative medicine, increased government funding for life sciences innovation, and growing adoption of cell and gene therapies across NHS institutions.
  • The market benefits from strong intellectual property protections and collaborative research ecosystems. Key drivers include rising demand for biobanking services, expansion of clinical trial infrastructure, and investment in personalized medicine initiatives.
  • UK pharmaceutical companies and academic institutions are increasingly outsourcing biopreservation services, while regulatory clarity post-Brexit has attracted international biotech firms to establish UK operations.
  • Continued momentum in stem cell research and immunotherapy development will sustain market growth through 2029..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The UK biopreservation market is valued at $118.3 million in 2024 and will reach $186.7 million by 2029, representing a 9.6% CAGR.
    • The UK's advanced healthcare infrastructure and regenerative medicine sector are primary drivers of biopreservation technology adoption.
    • Clinical applications and biobanking facilities in the UK are increasingly investing in biopreservation solutions to support cell and gene therapies.
    • The UK's regulatory environment and life sciences leadership position it as a strategic market for biopreservation innovation and expansion.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    UK Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    UK: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS82.7792.42102.32112.47124.13137.59151.51168.7110.5
    GENE BANKS49545965717886949.8
    HOSPITALS39434751566167749.5
    OTHER END USERS25283033363943479.4
    TOTAL195.77217.42238.32261.47287.13315.59347.51383.7110

    Target Audience

    • UK Biotech & Pharma Companies : Need market intelligence to assess competitive positioning, identify growth opportunities in cell therapy and regenerative medicine, and plan UK expansion strategies.
    • NHS Trusts & Hospital Networks : Require data on biopreservation solutions and vendor capabilities to inform procurement decisions and infrastructure investments for clinical applications and biobanking.
    • Private Equity & Investors : Seek UK market analysis to evaluate investment opportunities in biopreservation companies, assess market growth potential, and identify acquisition targets in the life sciences sector.
    • Academic Research Institutions : Need market insights to understand biopreservation technology trends, identify funding opportunities, and benchmark their research capabilities against UK and global standards.
    • International Market Entrants : Require UK-specific market data, regulatory guidance, and competitive analysis to successfully enter or expand operations in the British biopreservation market.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise valuation data for the UK biopreservation market with detailed forecasts through 2029, enabling accurate budget allocation and investment decisions for UK operations.
    • Regulatory & Compliance Insights : Understand UK-specific regulatory requirements, post-Brexit governance changes, and compliance frameworks that directly impact biopreservation technology adoption and market entry strategies.
    • Competitive Landscape Analysis : Identify leading UK biopreservation providers, emerging competitors, and market consolidation trends specific to the British life sciences sector.
    • Growth Driver Identification : Analyze UK-specific factors driving market growth including NHS adoption rates, academic research funding, and clinical trial expansion across British institutions.
    • Strategic Expansion Planning : Leverage UK market intelligence to develop targeted go-to-market strategies, partnership opportunities, and investment priorities within the British biopreservation ecosystem.

    Frequently asked questions

    What is the current size of the UK biopreservation market?

    The UK biopreservation market was valued at $118.3 million in 2024 and is expected to grow to $186.7 million by 2029.

    What is the growth rate of the UK biopreservation market?

    The UK biopreservation market is growing at a compound annual growth rate (CAGR) of 9.6% from 2024 to 2029.

    What are the main drivers of growth in the UK biopreservation market?

    Key drivers include the UK's advanced healthcare infrastructure, investment in regenerative medicine and cell therapy research, increasing adoption in clinical applications, and growing demand from biobanking facilities.

    Which sectors in the UK are adopting biopreservation technologies?

    The UK biopreservation market is being adopted across clinical applications, research institutions, biobanking facilities, and organizations focused on precision medicine and therapeutic development.

    How does the UK biopreservation market compare to other European markets?

    The UK's advanced regulatory framework, strong life sciences sector, and leadership in regenerative medicine position it as a key hub for biopreservation technology adoption within Europe.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status